RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Calhoun to Recombinant Proteins

This is a "connection" page, showing publications David Calhoun has written about Recombinant Proteins.
Connection Strength

0.805
  1. Stokes ES, Gilchrist ML, Calhoun DH. Prediction of improved therapeutics for fabry disease patients generated by mutagenesis of the a-galactosidase A active site, dimer interface, and glycosylation region. Protein Expr Purif. 2020 11; 175:105710.
    View in: PubMed
    Score: 0.170
  2. Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996 Apr; 174(4):1306-11.
    View in: PubMed
    Score: 0.126
  3. Meghdari M, Gao N, Abdullahi A, Stokes E, Calhoun DH. Carboxyl-terminal truncations alter the activity of the human a-galactosidase A. PLoS One. 2015; 10(2):e0118341.
    View in: PubMed
    Score: 0.117
  4. Maheshwari A, Christensen RD, Calhoun DA. Immune-mediated neutropenia in the neonate. Acta Paediatr Suppl. 2002; 91(438):98-103.
    View in: PubMed
    Score: 0.047
  5. Calhoun DA, Gersting JA, Lun?e M, Du Y, Christensen RD. Transfer of recombinant human granulocyte colony stimulating factor (rhG-CSF) from the maternal to the fetal circulation is not dependent upon a functional G-CSF-receptor. Placenta. 2001 Jul; 22(6):609-12.
    View in: PubMed
    Score: 0.045
  6. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother. 2000 Nov; 34(11):1257-61.
    View in: PubMed
    Score: 0.043
  7. Calhoun DA, Christensen RD, Edstrom CS, Juul SE, Ohls RK, Schibler KR, Sola MC, Sullivan SE. Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol. 2000 Sep; 27(3):733-53.
    View in: PubMed
    Score: 0.043
  8. Calhoun DA, Lun?e M, Du Y, Hutson AD, Veerman M, Christensen RD. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics. 2000 Feb; 105(2):392-7.
    View in: PubMed
    Score: 0.041
  9. Calhoun DA, Lun?e M, Du Y, Staba SL, Christensen RD. Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion. Pediatr Res. 1999 Dec; 46(6):767-71.
    View in: PubMed
    Score: 0.041
  10. Calhoun DA, Christensen RD. A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery. Am J Obstet Gynecol. 1998 Sep; 179(3 Pt 1):766-71.
    View in: PubMed
    Score: 0.037
  11. Calhoun DA, Christensen RD. The occurrence of Kostmann syndrome in preterm neonates. Pediatrics. 1997 Feb; 99(2):259-61.
    View in: PubMed
    Score: 0.033
  12. Calhoun DA, Li Y, Christensen RD. Effect of recombinant granulocyte colony-stimulating factor on erythropoiesis in the human fetus and neonate. Pediatr Res. 1996 Dec; 40(6):872-5.
    View in: PubMed
    Score: 0.033
  13. Christensen RD, Calhoun DA, Rimsza LM. A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit. Clin Perinatol. 2000 Sep; 27(3):577-601.
    View in: PubMed
    Score: 0.011
  14. Juul SE, Calhoun DA, Christensen RD. "Idiopathic neutropenia" in very low birthweight infants. Acta Paediatr. 1998 Sep; 87(9):963-8.
    View in: PubMed
    Score: 0.009
  15. Li Y, Juul SE, Morris-Wiman JA, Calhoun DA, Christensen RD. Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses. Pediatr Res. 1996 Sep; 40(3):376-80.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support